share_log

Maxim Group Initiates Coverage On Alterity Therapeutics With Buy Rating, Announces Price Target of $8

Maxim Group Initiates Coverage On Alterity Therapeutics With Buy Rating, Announces Price Target of $8

Maxim Group对Alterity Therapeutics启动覆盖,给予买入评级,并宣布目标价格为8美元。
Benzinga ·  2024/12/13 00:43  · 评级/大行评级

Maxim Group analyst Jason McCarthy initiates coverage on Alterity Therapeutics (NASDAQ:ATHE) with a Buy rating and announces Price Target of $8.

Maxim Group 分析师杰森·麦卡锡对Alterity Therapeutics(纳斯达克:ATHE)启动覆盖,并给予买入评级,同时宣布目标价格为8美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发